Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

March 31, 2017

Conditions
Urgency-frequency Syndrome
Interventions
BEHAVIORAL

EPNS

Electrical pudendal nerve stimulation Four sacral points are selected. The two upper points are located about 1 cm bilateral to the sacrococcygeal joint. On the upper points, a needle of 0.40 Х 100 mm is inserted perpendicularly to a depth of 80 to 90 mm to produce a sensation referred to the urethra or the anus. The locations of the two lower points are about 1 cm bilateral to the tip of the coccyx. On the lower points, a needle of 0.40 Х 100 or 125 mm is inserted obliquely towards the ischiorectal fossa to a depth of 90 to 110 mm to produce a sensation referred to the urethra. After the sensation referred to the above regions is produced, each of two pairs of electrodes from a G6805-2 Multi-Purpose Health Device is connected with the two ipsilaterally inserted needles.

DRUG

TT

Tolterodine tartrate (GSK, UK) 4mg per day is taken orally for six weeks

Trial Locations (1)

200030

Shanghai research institute of acupuncture and meridian, Shanghai

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

lead

Shanghai Institute of Acupuncture, Moxibustion and Meridian

OTHER

NCT02723279 - Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women | Biotech Hunter | Biotech Hunter